A1 Refereed original research article in a scientific journal
Adventures in radiosynthesis of clinical grade [68Ga]Ga-DOTA-Siglec-9
Authors: Käkelä Meeri, Luoto Pauliina, Viljanen Tapio, Virtanen Helena, Liljenbäck Heidi, Jalkanen Sirpa, Knuuti Juhani, Roivainen Anne, Li Xiang-Guo
Publisher: ROYAL SOC CHEMISTRY
Publication year: 2018
Journal: RSC Advances
Journal name in source: RSC ADVANCES
Journal acronym: RSC ADV
Volume: 8
Issue: 15
First page : 8051
Last page: 8056
Number of pages: 6
ISSN: 2046-2069
eISSN: 2046-2069
DOI: https://doi.org/10.1039/c7ra12423f
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/30431180
We finally managed to establish a protocol for generating Good Manufacturing Practice (GMP)-grade gallium-68-labelled 1,4,7,0-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugated sialic acid-binding immunoglobulin-like lectin 9 motif containing peptide ([Ga-68]Ga-DOTA-Siglec-9), the first radiopharmaceutical for positron emission tomography imaging of vascular adhesion protein 1.
Downloadable publication This is an electronic reprint of the original article. |